A Systematic Literature Review and Future Perspectives for Handling Big Data Analytics in COVID-19 Diagnosis.

Researchers

Journal

Modalities

Models

Abstract

In today’s digital world, information is growing along with the expansion of Internet usage worldwide. As a consequence, bulk of data is generated constantly which is known to be “Big Data”. One of the most evolving technologies in twenty-first century is Big Data analytics, it is promising field for extracting knowledge from very large datasets and enhancing benefits while lowering costs. Due to the enormous success of big data analytics, the healthcare sector is increasingly shifting toward adopting these approaches to diagnose diseases. Due to the recent boom in medical big data and the development of computational methods, researchers and practitioners have gained the ability to mine and visualize medical big data on a larger scale. Thus, with the aid of integration of big data analytics in healthcare sectors, precise medical data analysis is now feasible with early sickness detection, health status monitoring, patient treatment, and community services is now achievable. With all these improvements, a deadly disease COVID is considered in this comprehensive review with the intention of offering remedies utilizing big data analytics. The use of big data applications is vital to managing pandemic conditions, such as predicting outbreaks of COVID-19 and identifying cases and patterns of spread of COVID-19. Research is still being done on leveraging big data analytics to forecast COVID-19. But precise and early identification of COVID disease is still lacking due to the volume of medical records like dissimilar medical imaging modalities. Meanwhile, Digital imaging has now become essential to COVID diagnosis, but the main challenge is the storage of massive volumes of data. Taking these limitations into account, a comprehensive analysis is presented in the systematic literature review (SLR) to provide a deeper understanding of big data in the field of COVID-19.© The Author(s), under exclusive licence to The Japanese Society for Artificial Intelligence and Springer Nature Japan KK, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.